eft Ventricular Lead Acute Clinical Study - LILAC

Boston Scientific0 个研究点目标入组 10 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•Patients who are scheduled to receive (new implant or upgrade) either CRT-P or CRT-D system based on physician discretion
•Patients who are scheduled to have an LV lead implantation based on physician discretion
•Patients who are expected to tolerate approximately 30 minutes of study testing procedures per physician discretion
•Patients who are willing and capable of providing informed consent, participating in all testing associated with this clinical investigation at an approved clinical investigational center
•Patients whose age is 18 years or above, or of legal age to give informed consent specific to state and national law

•Patients who are allergic to the contrast media used in the study
•Patients who have a history of pocket or device related infection
•Patients who have any previous cardiac surgery within the last 3 months
•Patients who have concomitant cardiac surgery
•Patients who have unstable angina
•Patients who have myocardial infarction within the last 3 months
•Patients who are dependent on IV inotropes
•Patients who are in acute cardiac failure crisis
•Women of childbearing potential who are, or might be, pregnant at the time of the study (method of assessment upon physician*s discretion)
•Patients whose age is more than 80 years
•NYHA class IV patients
•Patients who are currently enrolled in another investigational study or registry that would directly interfere with the current study

发起方